BSUM Founder to Moderate “Code to Cure: AI’s Impact on Drug Discovery” at Atria University
15.1.2025
Juhani Lahdenperä, eMBA, M.Sc., founder of Biotech Startup Management (BSUM), has been invited to moderate the session "Code to Cure: AI's Impact on Drug Discovery", organized by Atria University, India, this Friday.
This distinguished event will explore the transformative role of artificial intelligence in drug discovery, bringing together experts from academia and industry to discuss the latest advancements, challenges, and opportunities in AI-driven therapeutics development.
Juhani’s Expertise
With over 20 years of hands-on experience in biotech and a specialization in AI applications through his eMBA, Juhani is uniquely positioned to lead this important discussion. As moderator, he will guide the panel through:
The latest breakthroughs in AI-powered drug discovery.
Strategies to overcome challenges in adopting AI technologies.
The future impact of AI in accelerating therapeutic innovation.
Why This Event Matters
AI is revolutionizing the way we discover and develop new therapies, offering the potential for faster, more cost-effective solutions to address global health challenges. This session is an opportunity to understand how cutting-edge AI technologies are shaping the future of life sciences.
